• IBA debuts compact synthesizer for radiopharmaceutical manufacturing
    May 14, 2025
  • Ratio Therapeutics plans radiopharmaceutical manufacturing site in Salt Lake City
    May 12, 2025
  • SHINE Technologies to acquire Lantheus’ SPECT division
    May 07, 2025
  • GE HealthCare announces FDA clearance for Aurora, dual-head SPECT/CT, and Clarify DL, AI-powered image reconstruction tech
    May 06, 2025
  • Blue Earth Therapeutics begins phase 2 trial of lutetium-based radioligand for prostate cancer
    May 06, 2025
  • SpectronRx passes FDA inspection with no observations for Indianapolis facility
    April 30, 2025
  • SHINE enters UAE market with Modawina partnership for Lu-177 distribution
    April 24, 2025
  • PET procedure volumes in US rose 12% in 2024
    April 23, 2025
  • SHINE and Sumitomo form partnership to expand radioisotope supply in Asia
    April 08, 2025
  • FDA clears Novartis’ Pluvicto for earlier use in PSMA-positive prostate cancer
    April 02, 2025
  • GE HealthCare takes full ownership of Nihon Medi-Physics in Japan
    April 01, 2025
Older Stories